8-K: EBR Systems Secures $36 Million Institutional Placement on ASX to Fuel Operations

EBR Systems, Inc. successfully completed an institutional placement on the Australian Securities Exchange, raising approximately U.S. $36.0 million before fees, through the issuance of 55.9 million CDIs at A$1.00 each.

Summary

• EBR Systems, Inc. (the "Company") entered into a Placement Agreement on May 22, 2025, for an institutional placement of 55,900,000 CHESS Depository Interests (CDIs) on the Australian Securities Exchange (ASX).
• Each CDI represents one share of the Company's common stock and was offered at a purchase price of A$1.00 per CDI, equivalent to U.S. $0.6434 at the current exchange rate.
• The Placement successfully raised approximately U.S. $36.0 million before deducting U.S. $2,247,718 in underwriting, management, selling, and advisory fees.
• J.P. Morgan Securities Australia Limited, Morgans Corporate Limited, Wilsons Corporate Finance Limited, and E&P Capital Pty Limited served as joint lead managers.
• The Placement was fully underwritten by J.P. Morgan Securities Australia Limited and Morgans Corporate Limited and settled on May 26, 2025 (U.S. Pacific time).
• The securities issued in the Placement were deemed exempt from registration under the U.S. Securities Act of 1933, as amended, in reliance on Regulation S, as transactions made outside the United States.
• Concurrently, the Company proposes to announce a non-underwritten Share Purchase Plan (SPP) aiming to raise approximately $6 million, with a cap of $15 million without Joint Lead Managers' consent.

Sentiment

Score: 8

Explanation: The document reports a successful and fully underwritten capital raise, which is a positive development for the company's financial position and future operations. While fees are noted, the primary outcome is a significant influx of capital.

Positives

• Successful completion of an institutional placement, raising approximately U.S. $36.0 million, providing significant capital for the Company's operations.
• The Placement was fully underwritten by J.P. Morgan Securities Australia Limited and Morgans Corporate Limited, indicating strong institutional support and commitment.
• The capital raise was conducted through CHESS Depository Interests (CDIs) on the ASX, diversifying the Company's funding sources and investor base.
• The Company is entitled to rely on ASIC Corporations (Offers of CHESS Depository Interests) Instrument 2025/180 for the Placement, streamlining regulatory compliance.

Negatives

• A substantial portion of the gross proceeds, U.S. $2,247,718, was deducted for underwriting, management, selling, and advisory fees, reducing the net capital raised.
• The issuance of 55,900,000 new CDIs will result in dilution for existing shareholders.

Risks

• ASX delisting or suspension of CDIs could occur for any reason, impacting liquidity and investor confidence.
• A significant market fall, specifically if the S&P/ASX 300 Index drops 10% or more below its pre-agreement level, could trigger termination rights for the Joint Lead Managers.
• Failure to obtain unconditional official quotation of Placement Securities on ASX by the required time, or subsequent withdrawal/qualification of approval, poses a risk.
• Placement Materials becoming misleading, deceptive, or omitting required information could lead to regulatory issues and termination.
• Alteration of the Company's capital structure without Joint Lead Managers' consent (outside of permitted issuances) is a risk.
• Inclusion of unsupported forecasts or forward-looking statements in Placement Materials could lead to liabilities.
• Delays of one business day or more in the Timetable for events up to and including the Settlement Date, without prior written consent, could result in termination.
• Company withdrawal of the Placement or inability to proceed with it would negate the capital raise.
• Insolvency of the Company or any of its Subsidiaries is a significant risk event.
• A material adverse change in the assets, liabilities, financial position, results, condition, operations, or prospects of the Group could lead to termination.
• Force majeure events, including new laws or governmental directives making it illegal for Joint Lead Managers to fulfill obligations, are risks.
• Fraudulent conduct by the Company or its affiliates, directors, or officers could lead to termination.
• A director or senior manager being charged with an indictable financial/corporate offense, or a director being disqualified, is a termination event.
• Changes in key management (Executive Chair, CEO, CFO, CMO, CCO, CCDO) or the board of directors could trigger termination.
• Investigations or proceedings by Government Agencies (e.g., ASIC, Takeovers Panel) related to the Placement could lead to termination.
• Breach of any terms and conditions of the Placement Agreement by the Company is a risk.
• Any representation or warranty made by the Company becoming incorrect, untrue, or misleading could lead to termination.
• Information supplied for Due Diligence Investigations or Placement Materials being false, misleading, or deceptive is a risk.
• A new adverse circumstance arising that should have been disclosed in Placement Materials could lead to termination.
• An obligation arising for the Company to issue an adverse cleansing notice to ASX is a risk.
• A change of control transaction or another offer to Securityholders that could result in a person acquiring 50% or more interest in the Company is a risk.
• Introduction of new laws or policies affecting capital markets or the Placement could lead to termination.
• Contravention of the Corporations Act, Listing Rules, or other applicable laws by the Company, or inability to allot securities, are risks.
• Market disruption and hostilities, including suspension of trading on major exchanges (ASX, HKEX, LSE, NASDAQ, NYSE), general moratorium on banking, adverse changes in financial/political/economic conditions, or escalation of hostilities/terrorist acts, are significant risks.

Future Outlook

The Company plans to conduct a non-underwritten Share Purchase Plan (SPP) to raise approximately $6 million concurrently with the institutional placement. A moratorium is in place for 90 days after the Allotment Date, restricting the Company from proposing or activating any equity or subordinated debt security buy-back, scheme, or arrangement, or allotting new securities, with specific exceptions for the Placement, existing employee/director incentive plans, dividend reinvestment plans, and the SPP (up to $15 million).

Industry Context

NA

Corporate Governance

Related Party Transactions

• The Company will review investor lists and use best efforts to identify related parties who have applied to participate in the Placement and bring them to the attention of the Joint Lead Managers.
• None of the Company's related parties or associates (or other persons referred to in Listing Rule 10.11) will participate in the Placement other than as permitted under applicable laws, including the Listing Rules.

Stakeholder Impact

• Shareholders: Will experience dilution due to the issuance of new CDIs, but the capital raise strengthens the Company's financial position, potentially supporting future growth and value.
• Institutional Investors: New institutional investors will acquire significant stakes in the Company through the Placement.
• Employees: A stronger financial position may provide greater job security and resources for company operations.
• Creditors: Improved liquidity and financial health may reduce credit risk.
• Management: The successful capital raise provides the necessary funding to execute strategic initiatives and business plans.

Next Steps

• Company to complete allotment and issue of the Placement Securities by 10:00 AM on May 28, 2025 (Allotment Date).
• Company to give the Cleansing Statement to ASX by 10:00 AM on May 28, 2025.
• Placement Securities issued on the Allotment Date are expected to commence trading on ASX (normal basis) on May 28, 2025.
• Dispatch of holding statements for the Placement Securities is scheduled for May 28, 2025.
• The Company proposes to announce and undertake a non-underwritten Share Purchase Plan (SPP) to raise approximately $6 million.

Key Dates

Keywords

EBR Systems, Capital Raise, Institutional Placement, ASX, CHESS Depository Interests, CDIs, Underwriting, SEC Filing, Form 8-K, Corporate Finance, Securities Exchange Act, Regulation S